MedPath

The success rate of two surgical approaches of Tympanoplasty

Not Applicable
Recruiting
Conditions
Chronic Otitis media.
Chronic serous otitis media
H65.20
Registration Number
IRCT20221002056073N2
Lead Sponsor
Oroumia University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

The patients with a mucoid type of chronic suppurative otitis media
Presence of conductive hearing loss with no sensorineural hearing loss in patients
Patients with good general physical condition
Patients with no evidence of infection in nose
Patients with throat and paranasal sinuses undergoing surgery for the first time for the concerned ear

Exclusion Criteria

Individuals younger than14 years of age and older than 55 years
Smokers
Participants with contralateral ear disease
Patients with cholesteatoma
Patients with otosclerosis
Patients with tympanosclerotic plaque or granulation tissue in the middle ear
Patients undergoing simultaneous mastoid surgery
Revision cases and associated poor general condition
Those with preoperative medical issues such as asthma
Diabetic patients
Patients with cardiovascular disease
Patients with chronic liver or renal diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Graft success rate. Timepoint: The graft success rate will be assessed between 3-6 months postoperatively. Method of measurement: Endoscopic assessment.;Pain severity. Timepoint: Pain severity will be assessed immediately after surgery and one day after surgery. Method of measurement: Pain severity will be evaluated and recorded by the patient using an 11-point numerical rating scale (NRS-11, range 0 to 10).;Duration of surgery. Timepoint: The duration of the surgery will be measured intraoperatively. Method of measurement: Using a chronometer (in minute).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath